Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Identification and Evaluation of the Cardiotoxicity of Cyclophosphamide in Hematopoietic Stem Cell Transplantation : Based on Spot Tracking Ultrasound

NCT05150080 is registered in ClinicalTrials.gov with Kai Mu as lead sponsor.

NCT NCT05150080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05150080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Identification and Evaluation of the Cardiotoxicity of Cyclophosphamide in Hematopoietic Stem Cell Transplantation : Based on Spot Tracking Ultrasound
Lead sponsor
Kai Mu
Phase
Observational
Overall status
Unknown status
Start date
July 10, 2021
Completion date
June 1, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardio-oncology, cardiotoxicity, cyclophosphamide, echocardiography, hematopoietic stem cell transplantation